Mr. Otto Folprecht reports
Vancouver, British Columbia / TheNewswire / June 15, 2015‐ – Vodis Pharmaceuticals Inc. (CSE: VP / FSE: 1JV / Q:VDQSF) (“Vodis” or the “Company”) has filed on SEDAR amended and restated unaudited interim financial statements for the six months ended September 30, 2014 and amended and restated unaudited interim financial statements for the nine months ended December 31, 2014 (together, the "Statements"), as well as the related amended and restated management's discussion and analysis.
The Company acquired all the outstanding shares of Vodis Innovative Pharmaceuticals Inc. ("VIP") on July 28, 2014. The acquisition was structured as a reverse takeover with VIP being the accounting acquirer of the Company (formerly Southbridge Resources Corp.). As a result of the reverse takeover, the Company's year-end changed from June 30th to the year-end of VIP, which is March 31st. The Statements have been amended and restated to reflect the quarter periods of VIP.
About Vodis Pharmaceutics Inc.
Vodis is one of Canada’s foremost brand names in the medical marijuana business. Its master grow teams have consistently won or placed at each competition they have entered with their “VIP” brand. The Company, with facilities in BC and Washington State, is also actively looking into expansion opportunities in other countries and US states.
For further information please contact:
Richard Schnoor
Head of Corporate Communications
Vodis Pharmaceuticals Inc.
8788 River Road
- See more at:
http://thenewswire.ca/...alyst2=release_id=16681#sthash.OdpViHmM.dpuf